Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1Myeloid 1

Conditions

Myeloproliferative Disorders 5Myelodysplastic Syndromes 5Leukemia 5Myelodysplastic-Myeloproliferative Diseases 4Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 4Primary Myelofibrosis 2Leukemia, Myelomonocytic, Chronic 2Anemia, Refractory, with Excess of Blasts 2Thrombocythemia, Essential 1Precancerous Conditions 1Polycythemia Vera 1Multiple Myeloma 1Mastocytosis, Systemic 1Leukemia, Promyelocytic, Acute 1Leukemia, Myeloid, Acute 1Hematologic Diseases 1Graft vs Host Disease 1Congenital Abnormalities 1Blast Crisis 1Anemia, Refractory 1Anemia 1

Interventions

avapritinib 5midostaurin 4masitinib 2Imatinib Mesylate 2sarilumab 1ripretinib 1obatoclax 1nilotinib 1ibrutinib 1dexamethasone acetate 1dexamethasone 21-phosphate 1denileukin diftitox 1auricularum 1Thalidomide 1Ranitidine 1Phlebotomy 1Interviews as Topic 1Ibuprofen 1Everolimus 1Diphenhydramine 1Dexamethasone 1Denosumab 1Dasatinib 1Cladribine 1Calcium Dobesilate 1Brentuximab Vedotin 1Azacitidine 1Acetaminophen 1AK002 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Mastocytosis, Systemic × Thalidomide × Myeloid × Clear all
NCT00769587 2025-09-22

Thalidomide in Treating Patients With Relapsed or Progressive Systemic Mastocytosis

Centre Hospitalier Universitaire, Amiens

Completed
MyeloidOther neoplasm

Precancerous Conditions, Mastocytosis, Systemic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡